Market News / Story
Arcutis’ ZORYVE® (roflumilast) Wins 2026 Marie Claire Beauty Award
GlobeNewswire ·
GlobeNewswire reports: WESTLAKE VILLAGE, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. , a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that ZORYVE® (roflumilast) cream 0.15% was presented with the 2026 “Best Prescription Skin Solution” Award by Marie Claire magazine. The magazine created this award category as part of its Marie Claire US Beauty Awards to recognize medical innovation…